As of 2026-03-03, the Relative Valuation of Ose Immunotherapeutics SA (OSE.PA) is (1.57) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 4.25 EUR, the upside of Ose Immunotherapeutics SA based on Relative Valuation is -137.0%.
The range of the Relative Valuation is (6.14) - 9.20 EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.0x - 9.5x | 6.8x |
| Forward P/E multiples | 5.6x - 9.4x | 7.5x |
| Fair Price | (6.14) - 9.20 | (1.57) |
| Upside | -244.5% - 116.6% | -137.0% |
| Date | P/E |
| 2026-03-02 | -2.66 |
| 2026-02-27 | -2.78 |
| 2026-02-26 | -2.86 |
| 2026-02-25 | -2.84 |
| 2026-02-24 | -2.74 |
| 2026-02-23 | -2.74 |
| 2026-02-20 | -2.77 |
| 2026-02-19 | -2.83 |
| 2026-02-18 | -2.82 |
| 2026-02-17 | -2.80 |
| 2026-02-16 | -2.80 |
| 2026-02-13 | -2.81 |
| 2026-02-12 | -2.82 |
| 2026-02-11 | -2.89 |
| 2026-02-10 | -2.96 |
| 2026-02-09 | -2.86 |
| 2026-02-06 | -2.78 |
| 2026-02-05 | -2.89 |
| 2026-02-04 | -3.02 |
| 2026-02-03 | -3.09 |
| 2026-02-02 | -3.19 |
| 2026-01-30 | -3.06 |
| 2026-01-29 | -3.11 |
| 2026-01-28 | -3.13 |
| 2026-01-27 | -3.14 |
| 2026-01-26 | -3.10 |
| 2026-01-23 | -3.13 |
| 2026-01-22 | -3.18 |
| 2026-01-21 | -3.07 |
| 2026-01-20 | -3.05 |
| 2026-01-19 | -3.10 |
| 2026-01-16 | -3.10 |
| 2026-01-15 | -3.12 |
| 2026-01-14 | -3.10 |
| 2026-01-13 | -3.16 |
| 2026-01-12 | -3.18 |
| 2026-01-09 | -3.21 |
| 2026-01-08 | -3.24 |
| 2026-01-07 | -3.34 |
| 2026-01-06 | -3.33 |
| 2026-01-05 | -3.29 |
| 2026-01-02 | -3.42 |
| 2025-12-31 | -3.32 |
| 2025-12-30 | -3.37 |
| 2025-12-29 | -3.30 |
| 2025-12-24 | -3.18 |
| 2025-12-23 | -3.21 |
| 2025-12-22 | -3.16 |
| 2025-12-19 | -3.17 |
| 2025-12-18 | -3.18 |